🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11779+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11779 recruiting trials

RecruitingNCT06820515

ATHNdataset Registry

👨‍⚕️ Tammuella Chrisentery-Singleton, M.D., American Thrombosis and Hemostasis Network📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT06635213

Effectiveness of Desensitisation and Pain Neuroscience Education in Patients With Carpal Tunnel Syndrome With Nosiplastic Pain

🏥 Kutahya Health Sciences University📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT05600140

Viewing Strategy Training in Children With (Cerebral) Visual Impairment

👨‍⚕️ Bianca Huurneman, PhD, Royal Dutch Visio📍 1 site📅 Started Oct 2024View details ↗
Phase 2, PHASE3RecruitingNCT06674148

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Qifangfeixian Granules in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)

👨‍⚕️ Zhang Huilan, PD, Tongji hospital affiliated to huazhong university of science and technology, Wuhan, hubei📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT06681610

Testing Pulse Stimulation to Improve Motor Function in People With ALS: A Pilot Study

🏥 Parc de Salut Mar📍 1 site📅 Started Oct 2024View details ↗
Enrolling by InvitationNCT06658470

Hand Disability In Systemic Sclerosis - Digital Ulcers

🏥 Pamukkale University📍 2 sites📅 Started Oct 2024View details ↗
Phase 1, PHASE2RecruitingNCT06649110

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

🏥 Novartis Pharmaceuticals📍 29 sites📅 Started Oct 2024View details ↗
Phase 3RecruitingNCT06439082

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

🏥 Novartis Pharmaceuticals📍 30 sites📅 Started Oct 2024View details ↗
Enrolling by InvitationNCT06658483

Hand ScleroDerma Lived Experience Scale in Individuals With Systemic Sclerosis

🏥 Pamukkale University📍 2 sites📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06613880

Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia

👨‍⚕️ Jun Shi, PhD, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT07479056

Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy

👨‍⚕️ Suk Seo, MD, PhD, The Catholic University of Korea Eunpyeong St. Mary's Hospital📍 1 site📅 Started Oct 2024View details ↗
Enrolling by InvitationNCT06826209

Comparison of Upper Extremity Functional Performance in Hemophilic and Healthy Children

🏥 Hacettepe University📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT07268833

Translating Single-cell Vulnerability Into Novel ALS Biomarkers and Therapeutic Targets: Towards a Liquid Nerve Biopsy

🏥 Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta📍 4 sites📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06558227

Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma

👨‍⚕️ Jason Wu, Suzhou Zelgen Biopharmaceuticals Co.,Ltd📍 1 site📅 Started Oct 2024View details ↗
NAEnrolling by InvitationNCT06477107

A Study of Cerebral Perfusion With tDCS in Chronic Hypoperfusion

👨‍⚕️ Zafer Keser, Mayo Clinic📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT06291350

Peridontal and Intestinal Microbiota in Patients With Gingival Scarring Pemphigoid

🏥 Centre Hospitalier Universitaire de Nice📍 3 sites📅 Started Oct 2024View details ↗
NARecruitingNCT05810571

Comparison of Postoperative Analgesic Efficacy of the Erector Spina Plane Block and Quadratus Lumborum Block in Open Nephrectomy: a Prospective Randomized Clinical Study

🏥 Kocaeli University📍 2 sites📅 Started Oct 2024View details ↗
Phase 4RecruitingNCT06653634

Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial

👨‍⚕️ Anna-Birgitte Aga, MD PhD, Oslo University Hospital📍 7 sites📅 Started Oct 2024View details ↗
EARLY_Phase 1RecruitingNCT06900049

Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy

🏥 Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Oct 2024View details ↗
RecruitingNCT06975982

Symptoms, Pulmonary Function, Muscle Strength, Exercise Capacity, and Frailty in Esophageal Atresia vs. Healthy Peers

👨‍⚕️ Deniz Inal-Ince, PhD, PT, Hacettepe University📍 1 site📅 Started Oct 2024View details ↗
← PreviousPage 219 of 589Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →